News & Announcements

TB Vaccine

Through the new project, researchers will analyze the effects of delivering the only current TB vaccine intravenously in an attempt to better prevent TB.

David Fryburg Q&A

In this Q&A, David Fryburg, M.D.,Chair of the Beta Cell Project Team, discusses the results of this significant project as it comes to a close.

Lung-MAP expansion

The Lung Cancer Master Protocol (Lung-MAP) is undergoing a major expansion to include patients with all non-small cell lung cancers.

Spotlight

Kidney Safety

FNIH Biomarkers Consortium and Critical Path Institute achieve the first ever qualification of a clinical safety biomarker by the U.S. Food and Drug Administration.

Driven to Cure, Inc. President and CEO, Andrew Lee

Recipient of the 2018 Charles A. Sanders, M.D., Partnership Award, Andrew had an unwavering commitment to advancing biomedical research for rare kidney cancers. He was an inspiration to thousands across the country. The FNIH will remember him as an extraordinary young man who exemplified what one person can achieve with vision, determination, self-sacrifice and great spirit.

 FNIH Rated #1 Charity

Join us for the 2019 FNIH Award Ceremony on May 22, 2019, featuring the presentation of the Lurie Prize in Biomedical Sciences

 

 

Front Page: